Cardiomyopathy News and Research

RSS

Cardiomyopathy is a group of diseases with primary, usually diffuse, involvement of the myocardium. The myocardial disease is not secondary to ischaemic, valvular, congenital or pericardial disease.

MRI-based blood flow testing offers better answers for unexplained chest pain

Chest pain may still be angina even when coronary angiogram testing shows the main heart arteries look clear. Using stress cardiac stress MRI testing to measure blood flow around the heart appears to improve diagnosis and patient quality of life.

10 Nov 2025

Action needed to fix gender gap in cardiac rehab

Addressing barriers to cardiac rehab for women is essential. The AHA's guidelines focus on enhancing access and promoting effective heart health strategies.

5 Nov 2025

UCLA experts call for individualized heart monitoring in breast cancer survivors

As breast cancer survival rates continue to climb - 4.3 million women in the U.S. are currently living with a history of the disease and in the next 10 years that number is expected to rise by another million - heart health has become an increasingly important part of survivorship care.

4 Nov 2025

Atrial dysfunction assessment tool may help identify stroke risk in people with ATTR-CM

A hidden atrial dysfunction may raise stroke risk in people with transthyretin amyloid cardiomyopathy (ATTR-CM); however, a non-invasive assessment tool may help identify those at increased risk, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2025.

3 Nov 2025

Genetic study reveals unique mutations in Chinese patients with hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy (HCM), a common genetic heart disorder, is often caused by mutations in sarcomere-related genes.

10 Oct 2025

Inflammation at the heart’s core: What clinicians and families can do now

Chronic low-grade inflammation is a key driver of cardiovascular disease, even when cholesterol is controlled. The ACC’s 2025 Scientific Statement highlights hsCRP as a routine risk marker and outlines lifestyle and pharmacologic anti-inflammatory strategies for prevention and treatment.

30 Sep 2025

Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease

In patients with heart failure (HF) caused by Chagas disease, sacubitril/valsartan was superior to enalapril for the composite primary endpoint, predominantly driven by a significant reduction in N-terminal pro-B-type natriuretic peptide (NT-proBNP), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Researchers uncover a promising new therapeutic target for Barth syndrome

Researchers at The Hospital for Sick Children (SickKids) have uncovered a promising new therapeutic target for Barth syndrome, a rare genetic condition with no current cure.

3 Sep 2025

Study reveals how type 2 diabetes directly alters the heart’s structure and energy systems

A new study from the University of Sydney has revealed how type 2 diabetes directly alters the heart’s structure and energy systems, offering vital insights into why people with diabetes are at greater risk of heart failure.

2 Sep 2025

Aficamten outperforms beta-blockers in treating patients with obstructive hypertrophic cardiomyopathy

Aficamten treatment was associated with significant improvements in exercise capacity and symptoms compared with metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in New England Journal of Medicine.

1 Sep 2025

Trial shows no meaningful gains with mavacamten in nonobstructive hypertrophic cardiomyopathy

Mavacamten treatment at 48 weeks was not associated with significant improvements in patient-reported health status or peak oxygen consumption compared with placebo in patients with symptomatic nonobstructive hypertrophic cardiomyopathy, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in New England Journal of Medicine.

1 Sep 2025

Cardiac device trial highlights importance of female representation in research

A cardiac device trial published in eClinicalMedicine shows that improving enrollment of females in such trials can better guide care for all patients.

25 Aug 2025

Breakthroughs in diagnosis and therapy for transthyretin amyloidosis

Transthyretin amyloidosis (ATTR) is caused by the misfolding and aggregation of the transthyretin (TTR) protein, leading to multi-organ damage.

21 Aug 2025

American College of Cardiology establishes a digital hypertrophic cardiomyopathy registry

The American College of Cardiology has established a digital hypertrophic cardiomyopathy (HCM) registry to learn more about one of the most common genetic cardiovascular diseases and provide more equitable access to treatment and care.

19 Aug 2025

New system uses ECG and blood markers for Takotsubo Syndrome

It's often mistaken for a heart attack, but Takotsubo cardiomyopathy – previously known as Broken Heart syndrome – is a serious and sometimes fatal heart condition increasingly reported in intensive care units (ICUs). Yet without a clear clinical pathway in ICUs, it's often missed, putting critically ill patients at risk.

19 Aug 2025

Cardiomyopathy News and Research

Further Reading

MRI-based blood flow testing offers better answers for unexplained chest pain

Action needed to fix gender gap in cardiac rehab

UCLA experts call for individualized heart monitoring in breast cancer survivors

Atrial dysfunction assessment tool may help identify stroke risk in people with ATTR-CM

Genetic study reveals unique mutations in Chinese patients with hypertrophic cardiomyopathy

Inflammation at the heart’s core: What clinicians and families can do now

Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease

Researchers uncover a promising new therapeutic target for Barth syndrome

Study reveals how type 2 diabetes directly alters the heart’s structure and energy systems

Aficamten outperforms beta-blockers in treating patients with obstructive hypertrophic cardiomyopathy

Trial shows no meaningful gains with mavacamten in nonobstructive hypertrophic cardiomyopathy

Cardiac device trial highlights importance of female representation in research

Breakthroughs in diagnosis and therapy for transthyretin amyloidosis

American College of Cardiology establishes a digital hypertrophic cardiomyopathy registry

New system uses ECG and blood markers for Takotsubo Syndrome

Researchers investigate how citrus bioflavonoid naringin could reduce inflammation and heart risk

New research highlights combined impact of genes and lifestyle on dilated cardiomyopathy

Substance use disorders increase risk of unplanned hospital readmissions

Blocking PTP1B protects the heart from obesity-induced damage

New gene editing approach targets mutation behind common genetic heart disease

Industry Focus eBook - Cell biology (5th edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News